Pharmaceuticals & Biotech Healthcare Sector

Tonix Pharmaceuticals Holding

Market Cap: US$186.2m

A biopharmaceutical company, focuses on developing and commercializing therapeutics to treat and prevent human disease.

Inhibrx Biosciences

Market Cap: US$186.2m

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

Omeros

Market Cap: US$185.2m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

High Tide

Market Cap: CA$252.5m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Eledon Pharmaceuticals

Market Cap: US$182.6m

Operates as a clinical stage biotechnology company.

Organigram Global

Market Cap: CA$251.7m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Panamera Holdings

Market Cap: US$182.0m

Does not have significant operations.

Kodiak Sciences

Market Cap: US$181.0m

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

Deltex Medical Group

Market Cap: US$180.6m

Manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, and internationally.

biote

Market Cap: US$180.4m

Operates in practice-building business within the hormone optimization space.

TriSalus Life Sciences

Market Cap: US$179.4m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.

Stereotaxis

Market Cap: US$178.0m

Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

Perspective Therapeutics

Market Cap: US$177.4m

Develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States.

Tiziana Life Sciences

Market Cap: US$176.1m

A biotechnology company, specializes in the development of transformative therapies for neurodegenerative and lung diseases in the United States.

ProQR Therapeutics

Market Cap: US$175.9m

A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

Inogen

Market Cap: US$175.6m

A medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.

Baird Medical Investment Holdings

Market Cap: US$175.3m

Engages in research and development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China.

scPharmaceuticals

Market Cap: US$174.7m

A pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care.

Utah Medical Products

Market Cap: US$174.6m

Provides medical devices for the healthcare industry worldwide.

AFT Pharmaceuticals

Market Cap: NZ$292.6m

Engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

DiaMedica Therapeutics

Market Cap: US$174.0m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

CVRx

Market Cap: US$173.9m

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.

Spectral Medical

Market Cap: CA$239.5m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

Lucid Diagnostics

Market Cap: US$172.0m

Operates as a commercial-stage medical diagnostics technology company in the United States.

SELLAS Life Sciences Group

Market Cap: US$171.7m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

INmune Bio

Market Cap: US$169.4m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

OmniAb

Market Cap: US$168.8m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

AC Immune

Market Cap: US$167.2m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

AVITA Medical

Market Cap: US$166.0m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Sight Sciences

Market Cap: US$165.4m

An ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases.

Prime Medicine

Market Cap: US$164.9m

A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.

Electromed

Market Cap: US$164.8m

Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

Procaps Group

Market Cap: US$163.6m

Develops, produces, and markets pharmaceutical solutions worldwide.

Avacta Group

Market Cap: UK£120.9m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

Profound Medical

Market Cap: CA$225.1m

Operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland.

RAPT Therapeutics

Market Cap: US$162.7m

Operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States.